Abbott Laboratories
NYSE:ABT · New York Stock Exchange
-$0.51 today
Vol 10.41M · Avg 13.17M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
-32.32%
Period High
$135.32
Period Low
$82.56
Latest
$88.38
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
UnitedHealth Group Incorporated
NYSE:UNH
$365.66B
Merck & Co., Inc.
NYSE:MRK
$281.68B
Novartis AG
NYSE:NVS
$280.83B
Novo Nordisk A/S
NYSE:NVO
$191.04B
Thermo Fisher Scientific Inc.
NYSE:TMO
$172.94B
Gilead Sciences, Inc.
NASDAQ:GILD
$152.42B
Intuitive Surgical, Inc.
NASDAQ:ISRG
$143.65B
Stryker Corporation
NYSE:SYK
$119.04B
Medtronic plc
NYSE:MDT
$101.32B
Boston Scientific Corporation
NYSE:BSX
$67.43B
What is the latest ABT filing?
The latest filing shown is SD dated May 27, 2026.
How many recent filings does ABT have?
Intrinsic Alpha currently shows 20 recent filings for ABT.
Explore More
Continue the stock analysis
Jump to another research area for this company.